μ-Opioid Inhibition of Ca2+Currents and Secretion in Isolated Terminals of the Neurohypophysis Occurs via Ryanodine-Sensitive Ca2+Stores
Authors:
Open Access
- 5 March 2014
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 34 (10) , 3733-3742
Abstract
μ-Opioid agonists have no effect on calcium currents (ICa) in neurohypophysial terminals when recorded using the classic whole-cell patch-clamp configuration. However, μ-opioid receptor (MOR)-mediated inhibition ofICais reliably demonstrated using the perforated-patch configuration. This suggests that the MOR-signaling pathway is sensitive to intraterminal dialysis and is therefore mediated by a readily diffusible second messenger. Using the perforated patch-clamp technique and ratio-calcium-imaging methods, we describe a diffusible second messenger pathway stimulated by the MOR that inhibits voltage-gated calcium channels in isolated terminals from the rat neurohypophysis (NH). Our results show a rise in basal intracellular calcium ([Ca2+]i) in response to application of [d-Ala2-N-Me-Phe4,Gly5-ol]-Enkephalin (DAMGO), a MOR agonist, that is blocked byd-Phe-Cys-Tyr-d-Trp-Orn-Thr-Pen-Thr-NH2(CTOP), a MOR antagonist. Buffering DAMGO-induced changes in [Ca2+]iwith BAPTA-AM completely blocked the inhibition of bothICaand high-K+-induced rises in [Ca2+]idue to MOR activation, but had no effect on κ-opioid receptor (KOR)-mediated inhibition. Given the presence of ryanodine-sensitive stores in isolated terminals, we tested 8-bromo-cyclic adenosine diphosphate ribose (8Br-cADPr), a competitive inhibitor of cyclic ADP-ribose (cADPr) signaling that partially relieves DAMGO inhibition ofICaand completely relieves MOR-mediated inhibition of high-K+-induced and DAMGO-induced rises in [Ca2+]i. Furthermore, antagonist concentrations of ryanodine completely blocked MOR-induced increases in [Ca2+]iand inhibition ofICaand high-K+-induced rises in [Ca2+]iwhile not affecting KOR-mediated inhibition. Antagonist concentrations of ryanodine also blocked MOR-mediated inhibition of electrically-evoked increases in capacitance. These results strongly suggest that a key diffusible second messenger mediating the MOR-signaling pathway in NH terminals is [Ca2+]ireleased by cADPr from ryanodine-sensitive stores.Keywords
This publication has 62 references indexed in Scilit:
- Type 1 ryanodine receptor knock-in mutation causing central core disease of skeletal muscle also displays a neuronal phenotypeProceedings of the National Academy of Sciences, 2011
- Voltage‐dependent κ‐opioid modulation of action potential waveform‐elicited calcium currents in neurohypophysial terminalsJournal of Cellular Physiology, 2010
- Calcium microdomains in regulated exocytosisCell Calcium, 2006
- u-Opioid Receptor Preferentially Inhibits Oxytocin Release from Neurohypophysial Terminals by Blocking R-type Ca2+ ChannelsJournal of Neuroendocrinology, 2005
- Burst Initiation and Termination in Phasic Vasopressin Cells of the Rat Supraoptic Nucleus: A Combined Mathematical, Electrical, and Calcium Fluorescence StudyJournal of Neuroscience, 2004
- The pharmacology of intracellular Ca2+-release channelsTrends in Pharmacological Sciences, 1994
- κ-opioid receptor stimulation increases intracellular free calcium in isolated rat ventricular myocytesLife Sciences, 1992
- Two types of calcium channels coexist in peptide-releasing vertebrate nerve terminalsNeuron, 1989
- Isolated neurosecretory nerve endings as a tool for studying the mechanism of stimulus-secretion couplingBioscience Reports, 1987
- Effects of Opioid Agonists and Antagonists on Oxytocin and Vasopressin Release in vitroNeuroendocrinology, 1985